PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
PROCEPT BioRobotics Corporation
NASDAQ:PRCTHealthcare · Medical - Devices
-5.42%$19.20
AH$19.20+0.00%vs close
Mkt Cap$1.1B
Float53.23M
O/S57.27M
Vol
$ Vol
RVOL
Inst Own93.0%
SI14.1%
Earnings
Dilution
Financials Summary
Revenue$308.05M
Net Income-$95.57M
Total Assets$508.08M
Free Cash Flow-$58.34M
Debt & Equity
Debt 18%
Equity 82%
Total Debt$78.48M
Total Equity$365.87M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in PRCT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$508.08M
Liabilities$142.21M
Accounts Receivable$83.53M
Accounts Payable$17.29M
Inventory$70.69M
PP&E (Net)$47.94M
Goodwill$0
Intangible Assets$709K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $308.05M | $224.5M | $136.19M | $75.01M | $34.47M | $7.72M | $6.17M |
| YoY Growth | 37.2% | 64.8% | 81.6% | 117.6% | 346.7% | 25.1% | - |
| Cost of Revenue | $111.83M | $87.4M | $65.14M | $37.93M | $18.61M | $8.97M | $8.05M |
| Gross Profit | $196.23M | $137.1M | $71.05M | $37.09M | $15.87M | -$1.25M | -$1.89M |
| Gross Margin | 63.7% | 61.1% | 52.2% | 49.4% | 46.0% | -16.3% | -30.6% |
| Research and Development | $71.28M | $62.3M | $48.45M | $28.98M | $18.99M | $16.27M | $13.15M |
| Selling, General, and Administrative | $228.81M | $171.41M | $131.77M | $88.83M | $51.04M | $30.27M | $28.52M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $300.08M | $233.71M | $180.22M | $117.81M | $70.03M | $46.55M | $41.66M |
| Operating Income (EBIT) | -$103.86M | -$96.61M | -$109.17M | -$80.72M | -$54.16M | -$47.8M | -$43.55M |
| Operating Margin | -33.7% | -43.0% | -80.2% | -107.6% | -157.1% | -619.4% | -705.9% |
| Interest Expense | $3.59M | $4.18M | $4M | $5.18M | $5.81M | $5.26M | $724K |
| Interest Income | $12.22M | $10.89M | $7.55M | $2.5M | $76K | $184K | $1.15M |
| Other Income (Expense) | $8.48M | $5.2M | $3.27M | -$6.43M | -$5.69M | -$5.22M | $1.57M |
| Income Before Tax (EBT) | -$95.38M | -$91.41M | -$105.9M | -$87.15M | -$59.85M | -$53.02M | -$41.98M |
| Income Tax Expense | $190K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$95.57M | -$91.41M | -$105.9M | -$87.15M | -$59.85M | -$53.02M | -$41.98M |
| Net Income Margin | -31.0% | -40.7% | -77.8% | -116.2% | -173.6% | -687.0% | -680.4% |
| Supplementary Data | |||||||
| EPS | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 | -1.51 | -1.25 |
| Diluted EPS | -1.72 | -1.75 | -2.24 | -1.96 | -1.37 | -1.51 | -1.25 |
| Weighted Average OS | 55.54M | 52.13M | 47.26M | 44.40M | 43.70M | 35.14M | 33.59M |
| EBITDA | -$85.41M | -$82M | -$98.09M | -$79.13M | -$50.72M | -$44.9M | -$39.76M |
| EBITDA Margin | -27.7% | -36.5% | -72.0% | -105.5% | -147.1% | -581.8% | -644.5% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $286.5M | $333.73M | $257.22M | $222.64M | $304.32M | $100.13M | $42.02M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $286.5M | $333.73M | $257.22M | $222.64M | $304.32M | $100.13M | $42.02M |
| Accounts Receivable | $83.53M | $83.5M | $48.38M | $15.27M | $4.46M | $1.55M | $1.1M |
| Inventory | $70.69M | $56.17M | $39.76M | $28.54M | $13.15M | $7.48M | $6.69M |
| Other Current Assets | $9.65M | $8.45M | $5.21M | $6.17M | $3.41M | $0 | $0 |
| Total Current Assets | $450.38M | $481.84M | $350.57M | $272.63M | $326.17M | $109.9M | $50.36M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $47.94M | $45.65M | $48.99M | $32.14M | $8.32M | $12.91M | $8.27M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $709K | $932K | $1.2M | $1.48M | $1.75M | $2.02M | $2.29M |
| Long-Term Investments | $3.04M | $3.04M | $3.04M | $3.04M | $777K | $777K | $691K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $6.02M | $2.56M | $919K | $51K | $0 | $356K | $378K |
| Total Long-Term Assets | $57.7M | $52.17M | $54.15M | $36.7M | $10.85M | $16.07M | $11.64M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $508.08M | $534.02M | $404.72M | $309.33M | $337.02M | $125.97M | $61.99M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $17.29M | $10.03M | $13.5M | $9.39M | $2.03M | $1.24M | $1.44M |
| Short-Term Debt | $2.21M | $1.91M | $1.68M | $2.13M | $2.1M | $6.26M | $0 |
| Current Income Tax Payable | $0 | $2.07M | $1.73M | $829K | $515K | $302K | $0 |
| Current Unearned Revenue | $13.05M | $9.56M | $5.66M | $2.85M | $1.02M | $233K | $106K |
| Other Current Liabilities | $10.07M | $10.09M | $8.2M | $7.47M | $4.61M | $2.15M | $2.9M |
| Total Current Liabilities | $65.8M | $53.13M | $45.93M | $35.29M | $16.24M | $14.53M | $6.79M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $51.62M | $51.47M | $51.34M | $51.21M | $50M | $44.41M | $23.22M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $147K | $324K | $517K | $1.78M | $1.7M | $1.98M | $2.75M |
| Total Long-Term Liabilities | $76.42M | $78.66M | $78.04M | $76.97M | $53.69M | $50.48M | $25.97M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $142.21M | $131.8M | $123.97M | $112.26M | $69.93M | $65.01M | $32.76M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $243.85M | $173.07M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$641.56M | -$545.99M | -$454.57M | -$348.68M | -$261.52M | -$201.67M | -$148.65M |
| Comprehensive Income & Other | $37K | $114K | $84K | -$6K | -$54K | -$14K | $4K |
| Other Stockholders' Equity | $1.01B | $948.21M | $735.32M | $545.75M | $528.61M | $262.63M | $177.88M |
| Total Equity | $365.87M | $402.22M | $280.75M | $197.07M | $267.09M | $60.96M | $29.23M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $508.08M | $534.02M | $404.72M | $309.33M | $337.02M | $125.97M | $61.99M |
| Supplementary Data | |||||||
| Total Debt | $78.48M | $80.25M | $79.2M | $77.32M | $54.1M | $54.76M | $23.22M |
| Net Debt | -$208.02M | -$253.47M | -$178.02M | -$145.32M | -$250.22M | -$45.37M | -$18.8M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$95.57M | -$91.41M | -$105.9M | -$87.15M | -$59.85M | -$53.02M | -$41.98M |
| Depreciation & Amortization | $6.39M | $5.23M | $3.81M | $2.84M | $3.32M | $2.86M | $1.49M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $451K | $0 | $0 |
| Stock-Based Compensation | $47.6M | $31.84M | $19.13M | $10.34M | $3.8M | $2.17M | $1.99M |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$898K | -$35.96M | -$33.1M | -$10.81M | -$2.91M | -$511K | $522K |
| Inventory | -$14.5M | -$17.23M | -$9.75M | -$15.25M | -$6.12M | -$3.1M | -$5.07M |
| Accounts Payable | $6.65M | -$2.15M | $5.79M | $3.96M | $812K | -$205K | -$260K |
| Other Working Capital | $909K | $8.02M | $10.9M | $10.61M | $3.52M | $3.34M | $1.28M |
| Total Working Capital Change | -$7.84M | -$47.33M | -$26.16M | -$11.49M | -$4.71M | -$483K | -$3.53M |
| Other Non-Cash Items | $433K | $2.45M | $1.11M | $5.08M | -$345K | $126K | -$1.8M |
| Net Cash from Operating | -$48.98M | -$99.21M | -$108M | -$80.38M | -$57.33M | -$48.34M | -$43.82M |
| Investing Activities | |||||||
| Capital Expenditures | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592K | -$233K | -$7.61M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $50.76M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592K | -$233K | $43.15M |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | -$1.2M | - | -$24.68M | -$24.53M |
| Common Stock Issuance | $11.19M | $164.52M | $161.71M | $0 | $172.36M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $15.6M | $6.09M | $2.42M | $5.04M | $5.6M | $1.99M |
| Net Cash from Financing | $11.19M | $180.13M | $167.79M | $3.61M | $262.12M | $106.77M | $26.53M |
| Forex Effect | -$74K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$47.22M | $76.5M | $34.59M | -$79.42M | $204.19M | $58.2M | $25.86M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$48.98M | -$99.21M | -$108M | -$80.38M | -$57.33M | -$48.34M | -$43.82M |
| Capital Expenditure | -$9.36M | -$4.41M | -$25.21M | -$2.65M | -$592K | -$233K | -$7.61M |
| Free Cash Flow | -$58.34M | -$103.62M | -$133.21M | -$83.03M | -$57.93M | -$48.58M | -$51.43M |
| Cash at Beginning | $336.76M | $260.26M | $225.67M | $305.1M | $100.91M | $42.71M | $16.85M |
| Cash at End | $289.54M | $336.76M | $260.26M | $225.67M | $305.1M | $100.91M | $42.71M |